Bio-Rad Laboratories, Inc.Class A vs Nvidia Corp
BIO vs NVDA — side-by-side comparison from reported financials. BIO leads 1, NVDA leads 9 of 10 comparable metrics.
Bio-Rad Laboratories, Inc.Class A
BIO · Technology
$366.16+1.60%Strong
Nvidia Corp
NVDA · Technology
$229.39-0.47%Mixed
| Metric | BIO | NVDA |
|---|---|---|
| Price | $366.16 | $229.39 |
| Market cap | $9.79B | $5.54T |
| Revenue (TTM) | $2.59B | $303B |
| Revenue growth | -2.7% | +100.0% |
| Net margin | 8.6% | 63.7% |
| Free cash flow | $353M | $127B |
| Net cash (debt) | $339M | $2.14B |
| 1-year price return | +21.8% | +19.1% |
| P/E | 44.3 | 28.6 |
| P/E vs own history (cheap-side %) | 26% | 96% |
| Dividend yield | — | 0.12% |
| Return on equity | 3% | 110% |
| Altman Z-score | 3.41 | — |
| CV checks passed | 9 of 10 | 10 of 10 |
| Employees | 7,450 | 42,000 |
Full résumé-style profiles: BIO CV · NVDA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.